Arabic Arabic English English French French German German
dark

Regeneron’s Antibody Cocktail Cuts Progression to Symptomatic COVID-19

Regeneron Pharmaceuticals announced the results from its Phase III trial of recently infected asymptomatic COVID-19 patients for its REGEN-COV (casirivimab with imdevimab) antibody cocktail. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Madinah: 124,000+ Patients Served by King Fahd Hospital in 3 Months

Next Post

HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity

Related Posts
Total
0
Share